Victoria A. Muggia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Victoria A. Muggia has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Yoram A. Puius
Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, United States
2 shared publications Aileen P. Tlamsa
Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York
1 shared publicationDaniel J. Goldstein
Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York
1 shared publication- Enver Akalin
Renal Division Montefiore Medical Center, Albert Einstein College of Medicine, Kidney Transplantation Program, Bronx, New York
1 shared publication Fauziya Parkar
Division of Nuclear Medicine, Department of Radiology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York
1 shared publication- Grace Y. Minamoto
Department of Medicine Division of Infectious Diseases Montefiore Medical Center Bronx New York USA
1 shared publication
Latest Publications
- 20 April 2025
- Published by Wiley in Transplant Infectious Disease
- Vol. 27 (3) , e70039
Proof of Concept that Implementation of a Multispecialty Educational Intervention May Improve Acceptance of Organs from Donors with HIV at a Tertiary Care Hospital: A Single‐Center Study
Background: People living with HIV have a higher waitlist mortality and decreased access to transplants. The enactment of the HIV Organ Policy Equity Act (HOPE Act) in 2013 was a step toward increasing the donor population. However, utilization of organs through the act has been less than initially anticipated, both nationally and initially at our center.Methods: To improve the acceptance of abdominal organs from donors with positive HIV tests (D+) for recipients with HIV (R+), we implemented a multidisciplinary educational intervention at our center in December 2020.Results: Comparing the preintervention period (March 2018–November 2020) to the postintervention period (December 2020–April 2022), the number of organs that were declined for potentially HIV‐related reasons decreased significantly from 91% to 63% (p = 0.004). The proportion of organs declined at our center for potentially HIV‐related reasons that were accepted later by another center was 40% (10/25) preintervention and 24% (12/49) postintervention (p = 0.2). The rate of transplants/patient‐years on our center's waiting list overall tripled (IRR 3.11; 95% CI 1.08–9.44, p = 0.036), with the rate of HIV D+/R+ transplants increasing more dramatically (IRR 16.3; 95% CI 2.90–305, p = 0.009).Conclusion: Intensive provider education may have an impact on improving rates of transplantation of HIV+ recipients and realizing the potential of the HOPE ACT.
- 20 April 2025
- Published by Wiley in Transplant Infectious Disease
- Vol. 27 (3) , e70039
Proof of Concept that Implementation of a Multispecialty Educational Intervention May Improve Acceptance of Organs from Donors with HIV at a Tertiary Care Hospital: A Single‐Center Study
Background: People living with HIV have a higher waitlist mortality and decreased access to transplants. The enactment of the HIV Organ Policy Equity Act (HOPE Act) in 2013 was a step toward increasing the donor population. However, utilization of organs through the act has been less than initially anticipated, both nationally and initially at our center.Methods: To improve the acceptance of abdominal organs from donors with positive HIV tests (D+) for recipients with HIV (R+), we implemented a multidisciplinary educational intervention at our center in December 2020.Results: Comparing the preintervention period (March 2018–November 2020) to the postintervention period (December 2020–April 2022), the number of organs that were declined for potentially HIV‐related reasons decreased significantly from 91% to 63% (p = 0.004). The proportion of organs declined at our center for potentially HIV‐related reasons that were accepted later by another center was 40% (10/25) preintervention and 24% (12/49) postintervention (p = 0.2). The rate of transplants/patient‐years on our center's waiting list overall tripled (IRR 3.11; 95% CI 1.08–9.44, p = 0.036), with the rate of HIV D+/R+ transplants increasing more dramatically (IRR 16.3; 95% CI 2.90–305, p = 0.009).Conclusion: Intensive provider education may have an impact on improving rates of transplantation of HIV+ recipients and realizing the potential of the HOPE ACT.
- 12 November 2020
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 67 (7) , 746-751
Gallium-67 Single-Photon Emission Computed Tomography Affects Management of Infections of Left Ventricular Assist Devices
Our institution employs gallium-67 single-photon emission computed tomography low-dose CT (Ga-SPECT-CT) to determine the presence and extent of left ventricular assist device (LVAD) infections. We present a retrospective single-center study of 41 LVAD recipients who underwent Ga-SPECT-CT from January 2011 to June 2018 to determine whether Ga-SPECT-CT led to changes in antimicrobial therapy, LVAD revision or exchange, or application for 1A exception. The average age was 56.6 years, predominantly male (80.5%) and diabetic (68.3%), divided between ischemic (48.8%) and nonischemic (51.2%) cardiomyopathy. The majority had HeartMate II devices (82.9%). Device-related infections were classified as possible (12.2%), probable (36.6%), proven (36.6%), or rejected (14.6%). Sensitivity was 68.6% and specificity was 100%. Most VAD-specific infections were percutaneous deep driveline infections (DRIs) (34.1%), and VAD-related infections were primarily bloodstream infections (31.7%). Staphylococcus aureus was the major pathogen isolated. Gallium-67 single-photon emission computed tomography low-dose CT resulted in changes in management in more than half (53.7%) of patients: starting (24.4%) or stopping (17.1%) antimicrobial therapy, LVAD revision (22.0%) or exchange (12.2%), and the application for 1A exception for transplant listing (17.1%). We conclude that Ga-SPECT-CT is an effective modality for determining the presence and extent of LVAD DRIs, and contributed to a change in management in more than half of cases.
- 12 November 2020
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 67 (7) , 746-751
Gallium-67 Single-Photon Emission Computed Tomography Affects Management of Infections of Left Ventricular Assist Devices
Our institution employs gallium-67 single-photon emission computed tomography low-dose CT (Ga-SPECT-CT) to determine the presence and extent of left ventricular assist device (LVAD) infections. We present a retrospective single-center study of 41 LVAD recipients who underwent Ga-SPECT-CT from January 2011 to June 2018 to determine whether Ga-SPECT-CT led to changes in antimicrobial therapy, LVAD revision or exchange, or application for 1A exception. The average age was 56.6 years, predominantly male (80.5%) and diabetic (68.3%), divided between ischemic (48.8%) and nonischemic (51.2%) cardiomyopathy. The majority had HeartMate II devices (82.9%). Device-related infections were classified as possible (12.2%), probable (36.6%), proven (36.6%), or rejected (14.6%). Sensitivity was 68.6% and specificity was 100%. Most VAD-specific infections were percutaneous deep driveline infections (DRIs) (34.1%), and VAD-related infections were primarily bloodstream infections (31.7%). Staphylococcus aureus was the major pathogen isolated. Gallium-67 single-photon emission computed tomography low-dose CT resulted in changes in management in more than half (53.7%) of patients: starting (24.4%) or stopping (17.1%) antimicrobial therapy, LVAD revision (22.0%) or exchange (12.2%), and the application for 1A exception for transplant listing (17.1%). We conclude that Ga-SPECT-CT is an effective modality for determining the presence and extent of LVAD DRIs, and contributed to a change in management in more than half of cases.